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Perinatal programming of the
kidney: is bigger always better?
To the Editor: Escribano et al.1 recently described that
a high-protein formula was associated with higher kidney
volumes in infants. Whether this has an effect on long-term
kidney and cardiovascular parameters (the programming
effect) remains to be determined. However, I feel that such
long-term effects may even turn out to be undesirable.
Low nephron numbers have been associated with a higher
blood pressure in the long run,2 caused by glomerular
hyperﬁltration.3 Renal size is often used as a marker for
nephron endowment, although many studies show no
association between nephron number and renal size.2 In
addition, nephron formation has ceased before term birth,
which indicates that effects of postnatal interventions, such as
a high-protein diet, will not lead to a higher nephron number:
the size increase is merely due to hypertrophy.
Glomerular hyperﬁltration has been shown to be more
detrimental when starting early in life. For instance, a congenital
solitary functioning kidney leads to signs of glomerular
hyperﬁltration and injury in 32% of children at the mean age
of 8.4 years,4 exceeding the risks of donor nephrectomy. In
addition, animal studies have shown that preventing hyperﬁltra-
tion during a short period before adulthood leads to a long-
lasting lower blood pressure.5 As the higher-protein formula did
lead to a signiﬁcant higher renal workload,1 this may start the
vicious circle of glomerular hyperﬁltration. It remains to be
determined whether this hypertrophy persists and what the
impact is on later blood pressure, but this may be unfavorable.
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The Authors Reply: In a recent study1 we demonstrated that
a higher protein intake in healthy infants during the ﬁrst
months of life was associated with an increase in kidney size.
Schreuder2 has questioned whether this renal overgrowth
may be beneﬁcial or harmful in the long term.
An increase in protein intake may lead to renal functional
overload caused by nitrogenous products derived from
protein metabolism, which can cause a compensatory kidney
overgrowth. Because the intervention of this trial occurred
after the nephrogenesis period, it is logical to think that
overgrowth must have been caused by a hypertrophy of the
nephron structures rather than an increase in the glomeruli
number.
We have also tested how high intake of protein causes
increased body mass for up to 2 years of life.3 This increase in
body mass may lead to a secondary increase of renal
workload. If this is not accompanied by an increase in the
excretory capacity (not increasing the nephron number), it
will create an imbalance that can promote the functional
overload. This single nephron hyperﬁltration would be at the
risk of progressive renal disease.4
If protein intake in the early stages of development is
reduced, we would be able to beneﬁt metabolic programming,
reducing later obesity risk. This measure may lead to smaller
kidneys, but with similar functional reserve, and not cause an
overload that could be harmful to later health. In this case,
smaller body mass and smaller kidneys could be better. The
follow-up studies attempted in this cohort are important to
explore the potential long-term effects.
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FSGS lesions in IgA nephropathy
To the Editor: The interesting and detailed morphological
assessments of injury in immunoglobulin A (IgA) nephro-
pathy reported by El Karoui et al.1 describe the frequent
presence of focal segmental glomerulosclerosis (FSGS) lesions
in patients with IgA nephropathy. A remarkably high number
of their adult patients, 101 of the total 128, had lesions termed
‘consistent with FSGS’, classiﬁed by this group as hyalinosis
and collapsing glomerulopathy. The authors invoke the
Columbia classiﬁcation of FSGS in making these distinctions.
The authors use the term ‘capillary collapse and obliteration’,
but the illustrations provided (their Figure 1) show instead
that the capillaries are solidiﬁed by excess matrix without the
characteristic implosion or retracted appearance typical of
idiopathic collapsing glomerulopathy as originally described
and as seen in a similar morphological form in HIV-
associated nephropathy. The interesting glomerular epithelial
cell proliferation is not, by application of the criteria proposed
in the Columbia classiﬁcation, sufﬁcient to classify these as
typical collapsing lesions.2 We propose that the authors
emphasize the poor prognosis of this aggressive sclerosing
lesion characterized by epithelial cell proliferation without
implosion of the capillary tuft, and not confound the already
complex terminology by attempting to ﬁt this into the
collapsing glomerulopathy category of the Columbia classi-
ﬁcation. To apply the collapsing terminology to these lesions
also implies that they are likely to share similar pathogenetic
mechanisms, which remains to be proven. The observation
that these lesions are linked to a poor prognosis is important,
and distinct recognition and terminology is their due. Perhaps
‘active proliferative sclerosis’ or ‘sclerosis with epithelial
reactivity’ would come closest to capturing the essence of
the lesions as described.
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The Authors Reply: We agree completely with the observa-
tion of Fogo et al.1 that the shrunken capillary loops in the
collapsing glomerulopathy of immunoglobulin A nephro-
pathy (IgAN) more frequently have the appearance of being
obliterated by extracellular matrix than by adhesion of
capillary walls, a difference perhaps related to adjacent
mesangial deposits. In this respect, our lesion does not
completely correspond to the appearance of collapsing
glomerulopathy, as carefully deﬁned in primary focal
segmental glomerulosclerosis (FSGS).2
In effect, the authors are waging a battle similar to that
waged years ago by the makers of Xerox and Frigidaire to
preserve the sanctity of a brand name. However, as then, this
battle has already largely been lost. The term has now been
employed with varying ﬁdelity in 20 different conditions
(including IgAN in an article3 cosigned by one of the authors
of the above letter1). Collapsing glomerulopathy has thus been
degraded from a speciﬁcally deﬁned entity to a more generic
term, often of dubious validity.
We prefer to retain the term collapsing glomerulopathy in
IgAN, emphasizing the similarities with the lesion as
classically deﬁned: (1) presence in a setting of clearcut
FSGS; (2) shriveling of the glomerular tuft with near-total
obliteration of capillary lumina; (3) marked halo-like
proliferation of the overlying epithelium (identical immuno-
histochemically4 to that in primary FSGS and HIV-associated
nephropathy); (4) rapid progression to end-stage renal
disease. For us, it comes closer to the original description
than many of the entities currently parading as ‘collapsing
glomerulopathy’.
That being the case, we feel it would be counterproductive
to substitute an entirely new designation of the sort that the
authors suggest. However, it would be reasonable to add the
modiﬁer ‘IgA-associated’ to acknowledge the deﬁnite differ-
ences between the original and the copy.
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